Colon‐Targeted Ginseng Polysaccharides‐Based Microspheres for Improving Ulcerative Colitis via Anti‐Inflammation and Gut Microbiota Modulation
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von De-Yang Huo und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China. Hauptthemen laut MEDLINE: Panax, Microspheres, Gastrointestinal Microbiome, Polysaccharides. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Key Research and Development Program, National Basic Research Program of China.
Abstract (Originalsprache)
Natural plant‐derived polysaccharides exhibit substantial potential for treating ulcerative colitis (UC) owing to their anti‐inflammatory and antioxidant properties and favorable safety profiles. However, their practical application faces several challenges, including structural instability in gastric acid, imprecise targeting of inflamed regions, and limited intestinal retention times. To address these limitations, pH‐responsive, colon‐targeting microspheres (pWGPAC MSs) are developed for delivering phosphorylated wild ginseng polysaccharides (pWGP) to alleviate UC. These pWGPAC MSs are fabricated by incorporating pWGP into calcium‐crosslinked alginate microspheres with subsequent chitosan surface modification to enhance mucosal adhesion. These pWGPAC MSs demonstrated exceptional stability under acidic conditions while enabling targeted release in the colon. In a mouse model of UC, the pWGPAC MSs effectively mitigated mucosal injury, attenuated inflammation, and restored intestinal barrier function. Further mechanistic investigations revealed that these pWGPAC MSs modulated the TLR4/MYD88 signaling pathway and promoted M2 macrophage polarization. Integrated microbiome and metabolome analyses demonstrated that these pWGPAC MSs regulated the gut microbiota composition and decreased pro‐inflammatory metabolite levels. In addition, these microspheres demonstrated promising safety profiles. Collectively, these findings establish pWGPAC MSs as a promising therapeutic strategy for the treatment of UC and provide a solid foundation for future clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chinese Medicinal Materials, Jilin Agricultural University, Changchun, 130118, China.
- Guizhou University of Traditional Chinese Medicine, Guiyang, 550025, China.
- College of Life Sciences, Jilin Agricultural University, Changchun, 130118, China.
- Jilin Provincial International Joint Research Center for the Development and Utilization of Authentic Medicinal Materials, Changchun, 130118, China.
ORCID-Profile: Wei Li
Förderung
- National Key Research and Development Program
- National Basic Research Program of China
Zitieren
APA
Huo, D. Y., Li, Y. F., Song, L. J., Zhang, W. X., Li, X. D., Zhang, J., Ren, S., Wang, Z., & Li, W. (2025). Colon‐Targeted Ginseng Polysaccharides‐Based Microspheres for Improving Ulcerative Colitis via Anti‐Inflammation and Gut Microbiota Modulation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404122
Vancouver
Huo DY, Li YF, Song LJ, Zhang WX, Li XD, Zhang J, et al. Colon‐Targeted Ginseng Polysaccharides‐Based Microspheres for Improving Ulcerative Colitis via Anti‐Inflammation and Gut Microbiota Modulation. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404122
BibTeX
@article{Huo2025,
author = {Huo, De-Yang and Li, Yan-Fei and Song, Ling-Jie and Zhang, Wen-Xin and Li, Xin-Dian and Zhang, Jing and Ren, Shen and Wang, Zi and Li, Wei},
title = {Colon‐Targeted Ginseng Polysaccharides‐Based Microspheres for Improving Ulcerative Colitis via Anti‐Inflammation and Gut Microbiota Modulation},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404122}
}
EUVIMED